Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to encourage tissue repair and promotes survival of heart muscle cells after a heart attack. Researchers tested the therapy in rats and showed that it is effective up to five weeks after injection. 

Scientists at Northwestern University and University of California San Diego have developed a new, potent injectable therapy that can protect the heart from damage after a heart attack. After showing success in cell culture, the scientists tested their new therapy in a rat model of heart attack. Following a single, low-dose intravenous injection, the animals experienced decreased inflammation and cell death along with improved cardiac function and increased growth of new blood vessels.

Mount Sinai-led research can transform how hospitals triage, risk-stratify, and counsel patients to save lives

A research team from Helmholtz Munich, the Technical University of Munich (TUM) and the TUM University Hospital has developed DeepNeo, an AI-powered algorithm that automates the process of analyzing coronary stents after implantation. The tool matches medical expert accuracy while significantly reducing assessment time. With strong validation in both human and animal models, DeepNeo has the potential to standardize monitoring after stent implantation and thus improve cardiovascular treatment outcomes.

Yuze “Alice” Sun, an electrical engineering professor, has been elected to The University of Texas at Arlington’s Academy of Distinguished Researchers for her contributions to technologies critical to health care, environmental monitoring and national defense.